Bioartificial skin
- PMID: 10971033
- DOI: 10.1159/000016772
Bioartificial skin
Abstract
The loss of skin has been one of the oldest, yet most frequent and costly problems in our health care system. To restore functional and esthetic integrity in patients with unstable or hypertrophic scars, in burn patients and after skin loss for hereditary, traumatic or oncological reasons, an armamentarium of reconstructive surgical procedures including autogenous, allogenous and xenogenous tissue transfer as well as implantation of alloplastic materials has been favored. For several decades there has been increasing interest focused on 'tissue engineering' of dermal, epidermal and full thickness skin substitutes by both biological and synthetic matrices. At our institution (Hannover Medical School), a collagen/glycosaminoglycan dermal regeneration matrix has been used for immediate dermal coverage after escharectomy in burn injuries as well as for dermal replacement in chronically unstable scars. This article gives an overview on the current state of the art in bioartificial skin as well as our personal experience with the collagen/glycosaminoglycan matrix for dermal replacement in different clinical situations.
Copyright 2000 S. Karger AG, Basel
Similar articles
-
[Administration of Integra on primary burn wounds and unstable secondary scars].Chirurg. 2000 May;71(5):558-63. doi: 10.1007/s001040050856. Chirurg. 2000. PMID: 10875014 German.
-
Combined use of a collagen-based dermal substitute and a fibrin-based cultured epithelium: a step toward a total skin replacement for acute wounds.Burns. 2004 Nov;30(7):713-9. doi: 10.1016/j.burns.2004.04.007. Burns. 2004. PMID: 15475148
-
Skin assessment of burn wounds covered with a collagen based dermal substitute in a 2 year-follow-up.Burns. 2004 Jun;30(4):399-401. doi: 10.1016/j.burns.2003.11.012. Burns. 2004. PMID: 15145202 No abstract available.
-
Tissue-engineered human living skin substitutes: development and clinical application.Yonsei Med J. 2000 Dec;41(6):774-9. doi: 10.3349/ymj.2000.41.6.774. Yonsei Med J. 2000. PMID: 11204828 Review.
-
[Porous matrix and primary-cell culture: a shared concept for skin and cornea tissue engineering].Pathol Biol (Paris). 2009 Jun;57(4):290-8. doi: 10.1016/j.patbio.2008.04.014. Epub 2008 Jul 3. Pathol Biol (Paris). 2009. PMID: 18602223 Review. French.
Cited by
-
Skin cancers and dermal substitutes: Is it safe? Review of the literature and presentation of a 2-stage surgical protocol for the treatment of non-melanoma skin cancers of the head in fragile patients.Int Wound J. 2018 Oct;15(5):756-768. doi: 10.1111/iwj.12924. Epub 2018 Jun 4. Int Wound J. 2018. PMID: 29863792 Free PMC article. Review.
-
Vacuum-assisted closure improves the incorporation of artificial dermis in soft tissue defects: Terudermis(®) and Pelnac(®).Int Wound J. 2011 Jun;8(3):261-7. doi: 10.1111/j.1742-481X.2011.00780.x. Epub 2011 Feb 25. Int Wound J. 2011. PMID: 21561535 Free PMC article.
-
Combined negative pressure wound therapy with irrigation and dwell time and artificial dermis prevents infection and promotes granulation formation in a ruptured giant omphalocele: a case report.BMC Pediatr. 2022 Nov 26;22(1):680. doi: 10.1186/s12887-022-03755-8. BMC Pediatr. 2022. PMID: 36435753 Free PMC article.
-
VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo.Langenbecks Arch Surg. 2007 May;392(3):305-14. doi: 10.1007/s00423-007-0194-1. Epub 2007 Apr 3. Langenbecks Arch Surg. 2007. PMID: 17404752
-
A full skin defect model to evaluate vascularization of biomaterials in vivo.J Vis Exp. 2014 Aug 28;(90):51428. doi: 10.3791/51428. J Vis Exp. 2014. PMID: 25226211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical